PharmaTher Holdings Ltd (TSE:PHRM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PharmaTher Holdings Ltd. announced they have canceled a planned meeting with the FDA after receiving satisfactory preliminary responses regarding their Ketamine product’s application. The company is addressing minor deficiencies noted by the FDA and plans to resubmit necessary information by January 2025.
For further insights into TSE:PHRM stock, check out TipRanks’ Stock Analysis page.